Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Rizzetto

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 26, 2016
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosisSilvia Martini, Marco Sacco, Silvia Strona, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver diseaseChiara Rosso, Lavinia Mezzabotta, Melania Gaggini, et al.
Journal of Hepatology|August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
European Journal of Gastroenterology & Hepatology|May 31, 2013
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical settingChiara Giordanino, Marco Sacco, Simone Ceretto, et al.
Therapeutic Drug Monitoring|November 15, 2012
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatmentAntonio D'Avolio, Alessia Ciancio, Marco Siccardi, et al.
Journal of Medical Virology|September 30, 2017
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agentsAlessia Ciancio, Roberta Bosio, Simona Bo, et al.
Gastroenterology|October 19, 2005
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing-Tsung Chang, Robert G Gish, Stephanos J Hadziyannis, et al.
Alimentary Pharmacology & Therapeutics|July 21, 2021
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantationChristophe Duvoux, Luca S Belli, James Fung, et al.
European Journal of Gastroenterology & Hepatology|June 9, 2007
Capsule enteroscopy vs. other diagnostic procedures in diagnosing obscure gastrointestinal bleeding: a cost-effectiveness studyRiccardo Marmo, Gianluca Rotondano, Emanuele Rondonotti, et al.
The American Journal of Gastroenterology|June 20, 2006
Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?Alessia Ciancio, Antonina Smedile, Chiara Giordanino, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
Liver International : Official Journal of the International Association for the Study of the Liver|June 26, 2016
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosisSilvia Martini, Marco Sacco, Silvia Strona, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver diseaseChiara Rosso, Lavinia Mezzabotta, Melania Gaggini, et al.
Journal of Hepatology|August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
European Journal of Gastroenterology & Hepatology|May 31, 2013
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical settingChiara Giordanino, Marco Sacco, Simone Ceretto, et al.
Therapeutic Drug Monitoring|November 15, 2012
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatmentAntonio D'Avolio, Alessia Ciancio, Marco Siccardi, et al.
Journal of Medical Virology|September 30, 2017
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agentsAlessia Ciancio, Roberta Bosio, Simona Bo, et al.
Gastroenterology|October 19, 2005
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing-Tsung Chang, Robert G Gish, Stephanos J Hadziyannis, et al.
Alimentary Pharmacology & Therapeutics|July 21, 2021
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantationChristophe Duvoux, Luca S Belli, James Fung, et al.
European Journal of Gastroenterology & Hepatology|June 9, 2007
Capsule enteroscopy vs. other diagnostic procedures in diagnosing obscure gastrointestinal bleeding: a cost-effectiveness studyRiccardo Marmo, Gianluca Rotondano, Emanuele Rondonotti, et al.
The American Journal of Gastroenterology|June 20, 2006
Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?Alessia Ciancio, Antonina Smedile, Chiara Giordanino, et al.
Pageof 20